Cargando…

Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update

The assessment of portal hypertension is a relevant step in the evaluation of newly diagnosed advanced chronic liver disease (ACLD). The current gold standard includes the invasive evaluation of hepatic venous pressure gradient (HVPG) and endoscopy. However, noninvasive or minimally invasive techniq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravaioli, Federico, Montagnani, Marco, Lisotti, Andrea, Festi, Davide, Mazzella, Giuseppe, Azzaroli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011072/ https://www.ncbi.nlm.nih.gov/pubmed/29977287 http://dx.doi.org/10.1155/2018/4202091

Ejemplares similares

Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
por: Ravaioli, Federico, et al.
Publicado: (2018)

Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis
por: Marasco, Giovanni, et al.
Publicado: (2021)

Lamivudine treatment for severe acute HBV hepatitis
por: Lisotti, Andrea, et al.
Publicado: (2008)

Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome
por: Dajti, Elton, et al.
Publicado: (2019)

Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?
por: Dajti, Elton, et al.
Publicado: (2021)

Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
por: Dajti, Elton, et al.
Publicado: (2021)

High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy
por: Azzaroli, Francesco, et al.
Publicado: (2013)

Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease
por: Serra, Carla, et al.
Publicado: (2023)

Ultrasonography for Noninvasive Assessment of Portal Hypertension
por: Maruyama, Hitoshi, et al.
Publicado: (2017)

Noninvasive Evaluation of Liver Fibrosis and Portal Hypertension After Successful Portoenterostomy for Biliary Atresia
por: Hukkinen, Maria, et al.
Publicado: (2019)

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis
por: Wang, Le, et al.
Publicado: (2017)

Noninvasive Evaluation of Portal Hypertension: Emerging Tools and Techniques
por: Snowdon, V. K., et al.
Publicado: (2012)

Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension
por: Raeven, Pierre, et al.
Publicado: (2020)

Prenatal Noninvasive Trio-WES in a Case of Pregnancy-Related Liver Disorder
por: Provenzano, Aldesia, et al.
Publicado: (2021)

Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Noninvasive Evaluation of Portal Hypertension Using a Supervised Learning Technique
por: Marozas, Mindaugas, et al.
Publicado: (2017)

Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?
por: Kara, David, et al.
Publicado: (2018)

Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
por: Mandorfer, Mattias, et al.
Publicado: (2023)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension
por: Cunningham, Morven E., et al.
Publicado: (2019)

Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis
por: Amer, Ibrahim F, et al.
Publicado: (2021)

A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
por: Marasco, Giovanni, et al.
Publicado: (2021)

Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
por: Hong, Won Ki, et al.
Publicado: (2014)

Hydatid Cysts of Liver and Portal Hypertension
por: Emre, Ali, et al.
Publicado: (1990)

Portal Hypertension and a Stiff Liver
por: D'Alitto, Felicia, et al.
Publicado: (2018)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Advances in therapeutic options for portal hypertension
por: Vilaseca, Marina, et al.
Publicado: (2018)

Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
por: Simbrunner, Benedikt, et al.
Publicado: (2020)

Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease
por: Ravaioli, Federico, et al.
Publicado: (2022)

Prevalence of Portal Hypertensive Gastropathy in Chronic Liver Disease and Correlation with the Severity of Liver disease
por: Tiwari, Pratap S, et al.
Publicado: (2019)

Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
por: Jagdish, Rakesh Kumar, et al.
Publicado: (2023)

Noninvasively Assessed Portal Hypertension Grade Predicts Post-Hepatectomy Liver Failure in Patients With HepatocellCarcinoma: A Multicenter Study
por: Wang, Jitao, et al.
Publicado: (2022)

Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis
por: Frazzoni, Leonardo, et al.
Publicado: (2021)

Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical
por: Boyer-Diaz, Zoe, et al.
Publicado: (2020)

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease
por: Boyer-Diaz, Zoe, et al.
Publicado: (2019)

Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
por: Simbrunner, Benedikt, et al.
Publicado: (2023)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Gut-liver axis signaling in portal hypertension
por: Simbrunner, Benedikt, et al.
Publicado: (2019)

Salvianolic Acid B Reducing Portal Hypertension Depends on Macrophages in Isolated Portal Perfused Rat Livers with Chronic Hepatitis
por: Zhao, Xin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nu5bb0n92detucagkksurium6l